Trial Profile
A Study to Evaluate the Antiplatelet Response Variability to Ticagrelor and to Determine the Relationship Between Reticulated Platelets and On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndrsomes (ACS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Apr 2016
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Ticagrelor (Primary)
- Indications Acute coronary syndromes
- Focus Pharmacodynamics; Therapeutic Use
- 05 Apr 2016 New trial record